New PCR screening packages at low all-inclusive prices - Intestine

PCR screening for intestinal diseases in suckling piglets and fattening pigs

Diarrheal diseases can lead to losses in pig production and fattening. Depending on the age group, certain pathogens are particularly frequently involved in diarrhea.
In suckling piglets, Escherichia coli (E. coli) and Clostridium perfringens (C. perfringens) are frequently detected in diarrhea problems, as are Rota and Coronaviruses.
Occasionally, parasites such as Cystoisospora suis may also cause problems. 


With increasing age of the animals, the germ spectrum shifts and while the pathogen E. coli is more likely to cause illness in rearing and fattening pigs as EPEC (enteropathogenic E. coli) or EDEC / STEC (edema disease), enteric infections with Salmonella, Brachyspira (dysentery) and Lawsonia (ileitis) are becoming increasingly important. Among the viral pathogens, rotaviruses are losing importance while coronaviruses (PEDV) can cause disease in all age groups.
Due to the demand for direct detection of bacterial pathogens from feces by PCR, we have adapted our typing PCRs for E. coli "virulence factors" and C. perfringens for direct detection from the native sample, feces as well as from small or large intestine material.

In the PCR- Screening "Neonatal Diarrhoe" we offer the following PCRs at a favorable package price:

·         E. coli incl. typing "virulence factors”
·         C. perfringens with determination of type A and C
·         Cystoisospora suis
·         Rotavirus A/C
·         PEDV/ TGEV

For older animals we have compiled the PCR- Screening "Finisher": 

·         E.coli incl. typing "virulence factors
·         Brachyspira hyodysenteriae
·         Lawsonia intracellularis
·         Salmonella

In the PCR Screening "Finisher plus" Rotavirus A/C and TGEV/PEDV are additionally examined.

Please note, however, that these tests are not preceded by a cultural bacteriological examination, so that resistance tests or the preservation of isolates for a possible subsequent vaccine production are not possible without further cultural examination.

print version

Status 1/2023